Recent advances and applications of CRISPR-Cas9 in cancer immunotherapy.
Liu Z, Shi M, Ren Y, Xu H, Weng S, Ning W, Ge X, Liu L, Guo C, Duo M, Li L, Li J, Han X.
Liu Z, et al. Among authors: ge x.
Mol Cancer. 2023 Feb 16;22(1):35. doi: 10.1186/s12943-023-01738-6.
Mol Cancer. 2023.
PMID: 36797756
Free PMC article.
Review.